Clocortolone Pivalate and Palmitoylethanolamide (PEA) Topical Combination

The combination of clocortolone pivalate (a topical corticosteroid) and palmitoylethanolamide (PEA, a nonsteroidal anti-inflammatory compound) is used for treating inflammatory skin conditions, particularly atopic dermatitis. **Clocortolone pivalate** is a moderate potency topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses. **Palmitoylethanolamide (PEA)** is an endogenous fatty acid that is often deficient in patients with atopic dermatitis. It possesses anti-inflammatory and neuroprotective effects. PEA has been shown to reduce pain and inflammation in various conditions. This combination is designed to leverage the anti-inflammatory properties of both compounds, with the PEA component potentially allowing for reduced use of the corticosteroid while maintaining efficacy. It is applied topically, typically twice daily.